[Retracted] Machine Learning of ZnO Interaction with Immunoglobulins and Blood Proteins in Medicine

Table 1

Serum immunoglobulins (Ig), hemoglobin level, and serum proteins in patients and controls in acute toxoplasmosis before interaction with ZnO nanoparticles.

Parameter tested	Tested group	Tested nos.	Mean ± SD	p value
IgA	Patients	25	220.67 ± 12.16	0.194
	Control	20	97.6 ± 22.34	0.237
IgM	Patients	25	267.08 ± 10.36	0.289
	Control	20	167.31 ± 7.61	0.323
IgG	Patients	25	1364.07 ± 6.92	0.395
	Control	20	1401.07 ± 2.37	0.481
Hemoglobin (g/dl)	Patients	25	9.14 ± 1.24	0.477
	Control	20	9.64 ± 1.62	0.481
Total protein (g/dl)	Patients	25	6.07 ± 2.67	0.486
	Control	20	5.97 ± 1.66	0.491
Albumin (g/dl)	Patients	25	4.67 ± 2.02	0.496
	Control	20	4.06 ± 1.68	0.417
Globulin (g/dl)	Patients	25	2.07 ± 1.80	0.350
	Control	20	2.02 ± 1.67	0.294
Protease activity (µmol/L)	Patients	25	684.27 ± 61.37	0.247
	Control	20	651.33 ± 50.63	0.207